| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000032240 |
| Receipt No. | R000036763 |
| Official scientific title of the study | Study on 24-hour Na excretion effect of sustained ARB Azilsartan and its effect on blood pressure |
| Date of disclosure of the study information | 2018/04/16 |
| Last modified on | 2018/04/13 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Study on 24-hour Na excretion effect of sustained ARB Azilsartan and its effect on blood pressure | |
| Title of the study (Brief title) | Study on the effect of Na excretion and blood pressure of Azilsartan | |
| Region |
|
|
| Condition | ||
| Condition | Hypertensive patients with complication of chronic kidney disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the effect of 24 hours Na excretion and blood pressure on Azilsartan. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Urinary Na excretion rate |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intervention group with Azilsartan for 12days | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Patients over 20 years of age
(2) CKD patients with hypertension thought to be unnecessary for dialysis introduction during the study period (3) Patients for whom consent is documented for participation in this study (4) Patients who have consent to hospitalization for participation in this study |
|||
| Key exclusion criteria | (1) Patients who are receiving ARB, ACE inhibitors, renin inhibitors within 2 weeks
(2) Patients falling under the contraindications of Azir Sultan (3) Patients with severe hypertension (4) Patients with CKDstage 5 or higher (5) patients with insulin treatment (6) Patients who are pregnant or nursing (7) Patients with severe liver dysfunction (8) Patients who are judged inappropriate for the research subject by the attending physician |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Kouichi Tamura |
| Organization | Yokohama City University Graduate School of Medicine |
| Division name | Department of Medical Science and Cardiorenal Medicine |
| Address | 3-9, Fukuura, Kanazawa-ku, Yokohama |
| TEL | 045-787-2800 |
| tamukou@yokohama-cu.ac.jp | |
| Public contact | |
| Name of contact person | Yuki Kawai |
| Organization | Yokohama City University Graduate School of Medicine |
| Division name | Department of Medical Science and Cardiorenal Medicine |
| Address | 3-9, Fukuura, Kanazawa-ku, Yokohama |
| TEL | 045-787-2800 |
| Homepage URL | |
| ykawai2017@gmail.com | |
| Sponsor | |
| Institute | Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Salt Science Research Foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036763 |